ライフサイエンスコーパス: NAD

1 NAD is the substrate for the CD157- and CD38-dependent p

2 NAD was replaced by NADP.

3 NAD(+) can directly and indirectly influence many key ce

4 NAD(+) depletion and autophagy induced by NAMPT inhibito

5 NAD(+) is a central metabolite participating in core met

6 NAD(+) is also an essential cofactor for non-redox NAD(+

7 NAD(+) is an essential metabolite participating in cellu

8 NAD(+) levels also affect DNA repair capacity as NAD(+)

9 NAD(+) repletion via nicotinamide riboside ameliorated d

10 NAD(+), its phosphorylated variant NAD(P)(+), and its re

11 NAD(+)-dependent maintenance of renal tubular metabolic

12 NAD(H)-channeling within the LDH-GAPDH complex can be an

13 NAD(P)H:quinone oxidoreductase 1 (NQO1) and mitochondria

14 NAD(P)H:quinone oxidoreductase 1 (NQO1) appears to be th

15 NAD-dependent deacetylase sirtuin-1 (SIRT1) is a class I

16 NAD/NADP was replaced by NADP/NADPH.

17 substrate interactions and coupling of H(2), NAD(P)H, and Fdx remain to be resolved.

18 n poly (ADP-ribose) polymerase-1 (PARP-1); a NAD(+)-consuming enzyme activated by strand break interm

19 abolic pathway, L-AHG is first oxidized by a NAD(P)(+)-dependent dehydrogenase (AHGD), which is a key

20 Sirtuin 1 (Sirt1) is a NAD(+)-dependent deacetylase capable of countering age-r

21 9 days of oral nicotinamide riboside (NR), a NAD precursor.RESULTSWe demonstrated that HF is associat

22 SIRT1, a NAD(+)-dependent deacetylase, is pivotal in regulating h

23 e EcD-based biosensor that incorporates ADH, NAD(+), Pd-NPs and Nafion showed no loss of enzyme activ

24 ersensitivity to salt stress, but not affect NAD concentration.

25 NR supplementation does not affect NAD metabolite concentrations in skeletal muscle.

26 Nmnat activities are essential for all NAD(+) biosynthesis routes, and understanding the regula

27 catalyzed electron transfer reactions among NAD(P)H, flavodoxin, and several ferredoxins, thus funct

28 SIRT1 (Sir2) is an NAD(+)-dependent deacetylase that plays critical roles i

29 Nicotinamide riboside (NR) is an NAD+ precursor that boosts cellular NAD+ concentrations.

30 Sirtuin 1 (SIRT1), an NAD(+)-dependent deacetylase, is a key regulator of cell

31 Mechanistically, SIRT2, an NAD+-dependent deacetylase, protected neurons from cispl

32 together, these findings place Rho-actin and NAD(+) upstream of spheroid formation and may suggest th

33 lementation bolsters skeletal muscle ATP and NAD(+) levels causing upregulated angiogenic pathways vi

34 UA significantly increased ATP and NAD(+) levels in mice skeletal muscle.

35 The analysis also suggests that ATP and NAD(P)H balancing cannot be assessed in isolation from e

36 eveloped to track and categorise how ATP and NAD(P)H pools are affected in the presence of a new path

37 of QS is important for NAD biosynthesis, and NAD participates in plant response to salt stress by aff

38 D73 impacts intracellular NAD(+) content and NAD(+)-dependent DNA repair capacity.

39 we analyzed the effect of CD38 deletion and NAD(+) supplementation on neuronal death and glial activ

40 he association of citrin with glycolysis and NAD+/NADH ratio led us to hypothesize that it may play a

41 report the crystal structures of hsNadE and NAD(+) synthetase from M. tuberculosis (tbNadE) with syn

42 dro-N-acetylneuraminic acid intermediate and NAD(+) regeneration.

43 zed primarily by LDH to generate lactate and NAD(+) and by SpxB and PDHc to generate acetyl-CoA.

44 ATP levels and NAD(+) levels were measured using in vivo (31)P NMR and

45 NADH and NAD(+) are a ubiquitous cellular redox couple.

46 utant in a dead-end complex with octanal and NAD(+) reveals an apolar binding site primed for aliphat

47 asing oxidative phosphorylation (OXPHOS) and NAD(+) generation.

48 tection by promoting calcium regulation, and NAD(+) dysregulation underlies Sirt1 dysfunction in SCA7

49 impairs mitochondrial electron transport and NAD(+) regeneration.

50 +) levels also affect DNA repair capacity as NAD(+) is a substrate for PARP-enzymes (mono/poly-ADP-ri

51 beta-nicotinamide adenine dinucleotide (beta-NAD) is an important inhibitory motor neurotransmitter i

52 ble specialized functions of the NEJ in beta-NAD metabolism by determining the degradation of 1,N(6)

53 Metabolism of beta-NAD at the neuroeffector junction (NEJ) is likely to be

54 Here, we reveal a link between NAD(+) capping and tissue- and hormone response-specific

55 precursor nicotinamide riboside (NR) boosts NAD(+) levels and improves diseases associated with mito

56 They display a bright NAD(P)H fluorescence signal and low uptake of voltage-de

57 ates that congenital malformations caused by NAD deficiency can occur independent of genetic disrupti

58 s, and late evening activity are restored by NAD(+) repletion to youthful levels with NR.

59 ate most of the incomplete and non-canonical NAD caps through their decapping, deNADding and pyrophos

60 variant in Haao, which alone does not cause NAD deficiency or malformations, the incidence of embryo

61 has bi-allelic missense variants that cause NAD deficiency-dependent malformations.

62 Katsuyama et al., demonstrated that the CD38/NAD/Sirtuin1/EZH2 axis reduces cytolytic CD8(+) T cell f

63 ith MHV induces a severe attack on host cell NAD(+) and NADP(+) Finally, we show that NAMPT activatio

64 1 decreases mitochondrial-but not whole-cell-NAD(+) content, impairs mitochondrial respiration, and b

65 s exceeds the rate of ATP turnover in cells, NAD(+) regeneration by mitochondrial respiration becomes

66 by a gradual decline in tissue and cellular NAD(+) levels in multiple model organisms, including rod

67 R) is an NAD+ precursor that boosts cellular NAD+ concentrations.

68 cetate and beta-hydroxybutyrate or cofactors NAD(+) and NADH.

69 ed a head-to-head comparison study of common NAD(+) precursors in various organisms and mapped their

70 l benefits to the cell of compartmentalizing NAD(+), and methods for measuring subcellular NAD(+) lev

71 expand the genotypic spectrum of congenital NAD deficiency disorders and further implicate mutation

72 fm2 oxidizes NADH to maintain high cytosolic NAD levels in supporting robust glycolysis and to transf

73 and the Nudix hydrolase Nudt12 in decapping NAD-capped RNAs (deNADding) in cells.

74 Further, decreased NAD(+) reduced the capacity to repair DNA damage induced

75 o salt stress, indicating that the decreased NAD contents in the mutant were responsible for its hype

76 eased 15-hydroxyprostaglandin dehydrogenase [NAD((+))], which degrades eicosanoids, was observed in E

77 in OADH mutants, to the nicotinate-dependent NAD metabolism.

78 that the nicotinamide adenine dinucleotide (NAD(+) ) precursor nicotinamide riboside (NR) boosts NAD

79 olysis of nicotinamide adenine dinucleotide (NAD(+)) and is a candidate molecule for regulating neuro

80 onical 5' nicotinamide adenine dinucleotide (NAD(+)) cap can tag certain transcripts for degradation

81 Nicotinamide adenine dinucleotide (NAD(+)) is a coenzyme for redox reactions, making it cen

82 hanges in nicotinamide adenine dinucleotide (NAD(+)) levels that compromise mitochondrial function tr

83 Nicotinamide adenine dinucleotide (NAD(+)) plays a critical role in energy metabolism and b

84 thesis of nicotinamide adenine dinucleotide (NAD(+)).

85 me of the nicotinamide adenine dinucleotide (NAD) de novo synthesis pathway.

86 lay lower nicotinamide adenine dinucleotide (NAD) levels, and an imbalance in the NAD metabolome that

87 es of the nicotinamide adenine dinucleotide (NAD) synthesis pathway, are causative of congenital malf

88 Nicotinamide adenine dinucleotide (NAD), a ubiquitous coenzyme, is required for many physio

89 esence of nicotinamide adenine dinucleotide (NAD)-capped RNAs in mammalian cells and a role for DXO a

90 cursor of nicotinamide adenine dinucleotide (NAD).

91 d cycle, OX-PHOS, nicotinamide dinucleotide (NAD(+) ) synthesis, and reversed the defects in Abeta ph

92 In this review, I discuss NAD(+) metabolism, how different subcellular pools of NA

93 Maternal and embryonic NAD levels were deficient.

94 sal bi-allelic variants in NADSYN1, encoding NAD synthetase 1, the final enzyme of the nicotinamide a

95 e into yeast mitochondria lacking endogenous NAD(+) transporters.

96 mapped their biochemical roles in enhancing NAD(+) levels.

97 sphoribosyltransferase (NAMPT), an essential NAD(+) biosynthetic enzyme in skeletal muscle, decreased

98 Measuring metabolism of 1,N(6) -etheno-NAD (eNAD) in colonic tunica muscularis and in SMCs, ICC

99 etermining the degradation of 1,N(6) -etheno-NAD (eNAD) in colonic tunica muscularis of wild-type, Cd

100 m1(-/-) and DR6(-/-), but not Wld(s) (excess NAD(+)) neurons, are capable of forming spheroids that e

101 different conformational states to exchange NAD(+) and substrate, which may enable PARP enzymes to a

102 -Neu5Ac and Neu5Ac, as well as to co-factors NAD and NADH.

103 onditions, is hampered by the lack of a fast NAD(+)-dependent desuccinylation assay in a physiologica

104 , we report that the cytosolic flavoprotein, NAD(P)H quinone dehydrogenase 1 (Nqo1), is strongly over

105 ge in aerobic glycolysis when the demand for NAD(+) is in excess of the demand for ATP.

106 These data suggest that when demand for NAD(+) to support oxidation reactions exceeds the rate o

107 fluxes were greatly in excess of demand for NAD(P)H for biosynthesis and larger than those measured

108 that the NadA domain of QS is important for NAD biosynthesis, and NAD participates in plant response

109 1 represents an additional gene required for NAD synthesis during embryogenesis, and NADSYN1 has bi-a

110 ted variant NAD(P)(+), and its reduced forms NAD(P)/NAD(P)H are all redox cofactors with key roles in

111 are established and regulated, and how free NAD(+) levels can control signaling by PARPs and redox m

112 ich catalyze the transfer of ADP-ribose from NAD(+) to macromolecular targets (namely, proteins, but

113 DP-ribose) (PAR) is rapidly synthesized from NAD(+) at sites of DNA damage to facilitate repair, but

114 ipts related to the hydrolase activity (e.g. NAD+ diphosphatase), which were significantly upregulate

115 trate, removing the 2' phosphate to generate NAD(H), and is a direct regulator of oxidative stress re

116 nfinement of the enzyme/cofactor couple (HBD/NAD(+)) and with a stable and selective low-potential fo

117 However, much remains to be learnt about how NAD(+) influences human health and ageing biology.

118 However, it remains largely unknown how NAD affects plant response to salt stress.

119 ture of persistent PARP1 foci and identified NAD+ interacting residues involved in the PARP1 exchange

120 a mammalian transporter capable of importing NAD(+) into mitochondria.

121 amide riboside, and CD38 inhibition improved NAD homeostasis, thereby alleviating telomere damage, de

122 This change in NAD(+)/NADH is caused by increased mitochondrial membran

123 Here, we show that this decrease in NAD(+) and Nmnat protein levels is specifically due to t

124 tively respond to increases and decreases in NAD(+).

125 ated with nominally significant increases in NAD(+), arginine, saturated long chain free fatty acids,

126 to the rare cases of biallelic mutations in NAD synthesis pathway genes.

127 NatB exhibit an approximate 50% reduction in NAD(+) levels and aberrant metabolism of NAD(+) precurso

128 s dietary precursor tryptophan, resulting in NAD deficiency.

129 ) inhibited alphaKGDH activity and increased NAD(+), which induced SIRT1-dependent autophagy in both

130 Markers of increased NAD+ synthesis-nicotinic acid adenine dinucleotide and m

131 levels in LECs potentially due to increased NAD(P)H utilization to maintain redox homeostasis.

132 Therefore, the inhibition of ACMSD increases NAD(+) levels.

133 We find that NOCT increases NAD(H) and decreases NADP(H) levels in a manner dependen

134 Increasing NAD levels may have the potential to improve mitochondri

135 d by prolonged fasting intervals, increasing NAD-dependent deacetylase sirtuin-1 signaling important

136 ental and nutritional factors that influence NAD(+) biosynthesis and renal resilience may lead to nov

137 at mammalian mitochondria can take up intact NAD(+), and identify SLC25A51 (also known as MCART1)-an

138 RP1) gene, leading to a higher intracellular NAD(+) availability, beneficial for a sufficient provisi

139 her expression of CD73 impacts intracellular NAD(+) content and NAD(+)-dependent DNA repair capacity.

140 Reduced intracellular NAD(+) levels suppressed recruitment of the DNA repair p

141 ncer, is suggested to regulate intracellular NAD(+) levels by processing NAD(+) and its bio-precursor

142 d the axon death molecule dSarm, but not its NAD(+) hydrolase activity, was required cell autonomousl

143 compound, in contrast to its next of a kind, NAD(P)H:quinone oxidoreductase 1 (NQO1).

144 ted transport system for NADP(+) and luminal NAD(+) biosynthetic enzymes integrate signals from a che

145 r redox couples in the mitochondrial matrix (NAD, NADP, thioredoxin, glutathione, and ascorbate) are

146 ted a fluorescence-based assay for measuring NAD(+)-dependent desuccinylation activity in cell lysate

147 highlights the importance of NAMPT-mediated NAD(+) biosynthesis in the production of cisplatin-induc

148 y that depletes the key cellular metabolite, NAD+, in response to nerve injury.

149 Mitochondrial NAD(+) transporters have been identified in yeast and pl

150 ralogue of SLC25A51) increases mitochondrial NAD(+) levels and restores NAD(+) uptake into yeast mito

151 nknown function-as a mammalian mitochondrial NAD(+) transporter.

152 l derivatives have the potential to modulate NAD(+) levels.

153 luorescent indicators, FiNad, for monitoring NAD(+) dynamics in living cells and animals.

154 was found to be a single component monomeric NAD(P)H-dependent FAD-containing monooxygenase having a

155 Most NAD(+) in mammalian cells is synthesized via the NAD(+)

156 egulation and interconnection among multiple NAD(+) biosynthesis pathways are incompletely understood

157 bese men and women increased skeletal muscle NAD+ metabolites, affected skeletal muscle acetylcarniti

158 The cellular NADH/NAD(+) ratio is fundamental to biochemistry, but the ext

159 d the resultant increase in cytoplasmic NADH/NAD(+) ratio diverts glucose precursors away from glucon

160 directly lowering the hepatic cytosolic NADH/NAD(+) ratio in mice.

161 marker of an elevated hepatic cytosolic NADH/NAD(+) ratio, also known as reductive stress.

162 the nicotinamide adenine dinucleotide (NADH/NAD(+)) ratio, and decreased intracellular glutathione l

163 Our work identifies an elevated hepatic NADH/NAD(+) ratio as a latent metabolic parameter that is sha

164 ith lactate increased the intracellular NADH/NAD(+) ratio and upregulated NF-kappaB activation after

165 Here, we established live monitoring of NADH/NAD(+) in plants using the genetically encoded fluoresce

166 pyruvate carrier (UK5099) decreased the NADH/NAD(+) ratio and reduced NF-kappaB activation.

167 changes in the extramitochondrial-free NADH:NAD(+) ratio signaled through the CtBP family of NADH-se

168 ood lactate:pyruvate ratio and improved NADH:NAD(+) balance in the heart and brain.

169 PDH-generated NADH because an increased NADH:NAD(+) ratio inhibits GAPDH.

170 As the intracellular NADH:NAD(+) ratio can be in near equilibrium with the circula

171 An elevated intracellular NADH:NAD(+) ratio, or 'reductive stress', has been associated

172 ate ratio, normalized the intracellular NADH:NAD(+) ratio, upregulated glycolytic ATP production and

173 s and thereby sustain the stress-induced NMN/NAD(+) salvage pathway.

174 ated DNA ligase IV is dependent upon ATP not NAD+ or ADP-ribose.

175 tion of additional genes involved in de novo NAD synthesis as potential causes of complex birth defec

176 own-regulation of NRF2 and its targets NQO1 (NAD(P)H quinone dehydrogenase 1) and SLC7A11 (solute car

177 of PARP-1 on H2B requires NMNAT-1, a nuclear NAD(+) synthase, which directs PARP-1 catalytic activity

178 Sirtuin 6 (SIRT6) is a nuclear NAD(+)-dependent deacetylase of histone H3 that regulate

179 glycerides alongside increased activities of NAD(P)H:Quinone Oxidoreductase 1, Carnitine Palmitoyl-Co

180 f intracellular NADP(+) with the activity of NAD kinase (NADK).

181 Conversely, augmentation of NAD(+) may protect the kidney tubule against diverse acu

182 This binding of NAD(+) to the ARM domain facilitated the inhibition of t

183 r-expressing BNA2, the first Biosynthesis of NAD(+) (kynurenine) pathway gene, reduces LD accumulatio

184 ensor of the cell, belonging to the class of NAD(+)-dependent deacetylases.

185 t highly sensitive and specific detection of NAD(+) metabolism in live cells and in vivo remains diff

186 n occur independent of genetic disruption of NAD biosynthesis.

187 analyzing the subcellular redox dynamics of NAD in living plant tissues has been challenging.

188 These results reveal effects of NAD(+) on metabolism and the circadian system with aging

189 sified catalytic mechanisms and evolution of NAD(P)(+)-dependent ALDHs.

190 Elevated expression of NAD(P)H:quinone oxidoreductase 1 (NQO1) is frequent in p

191 the LDH-GAPDH complex can be an extension of NAD(H)-channeling within each tetramer.

192 A major family of NAD(+) consumers in mammalian cells are poly-ADP-ribose-

193 trate two-photon autofluorescence imaging of NAD(P)H and FAD to nondestructively resolve spatiotempor

194 However, the potential impact of NAD(+) depletion on the brain tumor microenvironment has

195 is intrinsic to understanding the impact of NAD(+) on cellular signaling and metabolism.

196 AKI), substantial decreases in the levels of NAD(+) impair energy generation and, ultimately, the cor

197 with metabolic disease and reduced levels of NAD(+), yet whether changes in nucleotide metabolism con

198 in NAD(+) levels and aberrant metabolism of NAD(+) precursors, changes that are associated with a de

199 s in cells, as well as how the modulation of NAD(+) synthesis dynamically regulates signaling by cont

200 te (P5C) to proline through the oxidation of NAD(P)H.

201 tabolism, how different subcellular pools of NAD(+) are established and regulated, and how free NAD(+

202 transcripts displaying a high proportion of NAD(+) capping are instead processed into RNA-dependent

203 was critical to approach the initial rate of NAD(+)-dependent desuccinylation activity in crude cell

204 H and Fdx4- and Fdx11-dependent reduction of NAD(+) MS-based mapping identified an Fdx1-binding site

205 alyzed the flavodoxin-dependent reduction of NAD(P)(+), Fdx2-dependent oxidation of NADH and Fdx4- an

206 Both Fdx1-dependent reductions of NAD(+) and NADP(+) were cooperative.

207 tate dehydrogenase-catalyzed regeneration of NAD(+) from GAPDH-generated NADH because an increased NA

208 ing of the molecular basis and regulation of NAD(+) metabolism.

209 findings reveal a direct, underlying role of NAD dysregulation when telomeres are short and underscor

210 Although the central role of NAD in plant metabolism and its regulatory role have bee

211 iously uncharacterized and essential role of NAD(+) capping in dynamically regulating transcript stab

212 The numerous biological roles of NAD(+) are organized and coordinated via its compartment

213 etase enzyme NadE catalyzes the last step of NAD(+) biosynthesis, converting nicotinic acid adenine d

214 st that CD38 deletion and supplementation of NAD(+) may protect transected axon cell-autonomously aft

215 Supplementation of NAD(+) with nicotinamide riboside slowed the axon degene

216 genes required for the de novo synthesis of NAD were previously identified in individuals with multi

217 c development by disrupting the synthesis of NAD, a key factor in multiple biological processes, from

218 ) gene required for the de novo synthesis of NAD.

219 Understanding of NAD(+) metabolism provides many critical insights into h

220 ndrial respiration, and blocks the uptake of NAD(+) into isolated mitochondria.

221 mechanisms that distinguish SIRT6 from other NAD(+)-dependent deacylases.

222 e riboside (NR), while down-regulating other NAD biosynthetic pathways.

223 iant NAD(P)(+), and its reduced forms NAD(P)/NAD(P)H are all redox cofactors with key roles in energy

224 d by DCF/dihydroethidium staining, perturbed NAD-to-NADH and glutathione-to-glutathione disulfide rat

225 ry, we established a technique for in planta NAD redox monitoring to deliver important insight into t

226 Sirtuins have been shown to possess NAD(+)-dependent desuccinylation activity in vitro and i

227 te intracellular NAD(+) levels by processing NAD(+) and its bio-precursor, nicotinamide mononucleotid

228 The prokaryotic NAD synthetase enzyme NadE catalyzes the last step of NA

229 One of these, the putative NAD(P)H nitroreductase YfkO, has been reported to be inv

230 merization of TIR effector domains and rapid NAD(+) cleavage.

231 erived macrophages had greater redox ratios [NAD(P)H/FAD intensity] compared with passively migrating

232 is also an essential cofactor for non-redox NAD(+)-dependent enzymes, including sirtuins, CD38 and p

233 al redox ratio measurements revealed reduced NAD(P)H levels in LECs potentially due to increased NAD(

234 ired enzymatic activity and severely reduced NAD levels.

235 mitochondrial complex III but can regenerate NAD+ by expression of the NADH oxidase from Lactobacillu

236 -CoA generated by PFL was used to regenerate NAD(+) with a subset used in capsule production, while t

237 FiNad sensors cover physiologically relevant NAD(+) concentrations and sensitively respond to increas

238 n E3 ligases in NatB mutants did not restore NAD(+) levels.

239 ses mitochondrial NAD(+) levels and restores NAD(+) uptake into yeast mitochondria lacking endogenous

240 thesis or increasing ATP hydrolysis restores NAD(+)/NADH homeostasis and proliferation even when gluc

241 e slowed down and even reversed by restoring NAD(+) levels.

242 ession of genes encoding enzymes for salvage NAD synthesis from nicotinamide (NAM) and nicotinamide r

243 Here we show that the Homo sapiens NAD(+) synthetase (hsNadE) lacks substrate specificity f

244 gy metabolism and are substrates for several NAD-consuming enzymes (e.g. poly(ADP-ribose) polymerases

245 containing dehydrogenase FdsABG is a soluble NAD(+)-dependent formate dehydrogenase and a member of t

246 senolytics, metformin, acarbose, spermidine, NAD(+) enhancers and lithium.

247 ing the compartmentalization of steady-state NAD(+) levels in cells, as well as how the modulation of

248 rase activity catalyzes the final two steps, NAD(+)-dependent dehydrogenation and iron chelation.

249 gulates signaling by controlling subcellular NAD(+) concentrations.

250 AD(+), and methods for measuring subcellular NAD(+) levels.

251 abilized by binding of SARM1's own substrate NAD+ in an allosteric location, away from the catalytic

252 The PARP substrate NAD(+) is synthesized from 5-phosphoribose-1-pyrophospha

253 acillus cereus The geometry of the substrate-NAD(+) interactions is finely arranged to promote hydrid

254 lformations and the importance of sufficient NAD precursor consumption during pregnancy.

255 cer types and is essential for supplementing NAD+ for glycolysis and NADH for oxidative phosphorylati

256 s the source of the adenylate group and that NAD+, unlike ATP, enhances ligation by supporting multip

257 d break repair, we attempted to confirm that NAD+ and ADP-ribose can be used as co-factors by human D

258 Here, we provide evidence that NAD+ does not enhance ligation by pre-adenylated DNA lig

259 We found that NAD(+)-dependent ADP-ribosylation of histone H2B-Glu35 b

260 Our data show that NAD deficiency as a cause of embryo loss and congenital

261 We show that NAD(+) is an unexpected ligand of the armadillo/heat rep

262 These findings suggest that NAD(+) mediates self-inhibition of this central pro-neur

263 The NAD+-dependent deacetylase and mono-ADP-ribosyl transfer

264 The NAD+-dependent protein SIRT1 deacetylates RECQL4 in vitr

265 nthesis of UDP-glucuronic acid can alter the NAD(+)/NADH ratio via the enzyme UDP-glucose dehydrogena

266 ha-ketoglutarate (alphaKG) abundance and the NAD(+)/NADH ratio, indicating that constitutive endoplas

267 wed that positive electric field between the NAD(H) binding sites on LDH and GAPDH tetramers can merg

268 transcripts for degradation mediated by the NAD(+) decapping enzyme DXO1.

269 This bifunctional enzyme couples the NAD(+) synthetase and glutaminase activities through an

270 nd to trigger this cascade by decreasing the NAD(+) /NADH ratio and NHEJ-repair in vitro and in diabe

271 their continued turnover likely to free the NAD(+) molecules.

272 eotide (NAD) levels, and an imbalance in the NAD metabolome that includes elevated CD38 NADase and re

273 des in the S-nitrosylation assay, 5.8 in the NAD(+) hydrolysis assay, and 6.8 in the enzymatic ADP-ri

274 milar malformations when their supply of the NAD precursors tryptophan and vitamin B3 in the diet was

275 are sensitive to selective inhibition of the NAD(+) salvage pathway enzyme nicotinamide phosphoribosy

276 ent with FK866, a selective inhibitor of the NAD(+) salvage pathway enzyme nicotinamide phosphoribosy

277 Disruption of the NAD(+)-binding site or the ARM-TIR interaction caused co

278 response to DNA damage and occupancy of the NAD(+)-binding site, the interaction of HPF1 with PARP1

279 ion of ubiquinol and the regeneration of the NAD+ and FAD cofactors, and complex III oxidizes ubiquin

280 Moreover, mutation analyses of the NAD+ interacting residues of PARP1 showed that PARP1 can

281 alate-aspartate shuttle, which regulates the NAD+/NADH ratio between the cytosol and mitochondria.

282 We further demonstrated that the NAD-dependent protein deacetylase, SIRT7, and the FOXO4

283 +) in mammalian cells is synthesized via the NAD(+) salvage pathway, where nicotinamide phosphoribosy

284 Supplementation with the NAD precursor, nicotinamide riboside, and CD38 inhibitio

285 tal structure of RgNanOx in complex with the NAD(+) cofactor showed a protein dimer with a Rossman fo

286 ere, we reveal that supplementation with the NAD(+) precursor nicotinamide riboside (NR) markedly rep

287 artments, and many are known targets of the (NAD(+))-dependent desuccinylase SIRT5.

288 Overall, reversal of these outcomes through NAD(+) or NMN supplementation was independent of CD73.

289 s of 5'caps has revealed that in addition to NAD, mammalian RNAs also contain other metabolite caps i

290 This two-step reaction is associated to NAD(+) regeneration, essential for glycolysis.

291 D accumulation during aging is not linked to NAD(+) levels, but is anti-correlated with metabolites o

292 icotinic acid adenine dinucleotide (NaAD) to NAD(+) Some members of the NadE family use l-glutamine a

293 t respond to the alarmone ppGpp, to PRPP, to NAD(+), to adenosine and cytidine diphosphates, and to p

294 cket that display peptide-bond flipping upon NAD(+) binding in proper NADH dehydrogenases.

295 ) or a chain of ADPR units to proteins using NAD as the source of ADPR.

296 ed that human DNA ligase IV can also utilize NAD+ and, to a lesser extent ADP-ribose, as the source o

297 NAD(+), its phosphorylated variant NAD(P)(+), and its reduced forms NAD(P)/NAD(P)H are all

298 The ultimate diagnoses were NAD = 43 (49%), CD = 17 (19%), IBS = 14 (16%), NSAIDs =

299 Despite this importance, whether NAD(+) capping dynamically responds to specific stimuli

300 the treatment of conditions associated with NAD(+) dysregulation.